The ability to detect multiple contrast agents simultaneously would greatly enhance Optical Coherence Tomography (OCT) images, providing nuanced biological context to physiological structures. However, previous OCT contrast agent work has been limited to scenarios where only a single contrast agent could be robustly detected within each voxel. We present a novel spectroscopic technique for de-mixing the spectral signal from multiple OCT contrast agents within a single voxel. We validate our technique in vitro and also demonstrate in vivo imaging of three spectrally distinct gold nanobipyramids, trafficking within the lymphatic system of a live mouse. This approach opens the door to a much broader range of pre-clinical and clinical OCT applications where multiplexed labeling is desirable.
Main Results:Optical Coherence Tomography (OCT) is an interferometric imaging technique that allows for non-invasive 3D tomography of the scattering properties of tissue at micron resolution, with improved depth sectioning and imaging depth compared to incoherent imaging 1 . A significant limitation of OCT, however, is the lack of multiplexed biological labeling techniques that are available to other imaging techniques (e.g. fluorescent markers), which enable localization of cell types, patterns of protein expression, and imaging of lymph/blood vessels 2 . The majority of previous work has focused on use of a single contrast agent, such as absorptive dyes 3 , microbeads 4,5,6 , and gold nanoparticles 7,8,9 . Two-plex imaging of gold nanoparticles has been demonstrated, but only under the assumption that each voxel contained a single type of contrast agent 10,11 . The biological applications of contrast-enhanced OCT techniques would be greatly expanded by the ability to distinguish multiple species of the contrast agent 12 within a single voxel.